Phase II Clinical Chemoprevention Trial of Weekly Erlotinib Before Bladder Cancer Surgery
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2018
Price : $35 *
At a glance
- Drugs Erlotinib (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 12 Apr 2018 Status changed from recruiting to discontinued.
- 05 Mar 2018 Planned primary completion date changed from 30 Mar 2018 to 1 Dec 2018.